Protecting HIV-exposed infants from severe infections
Part of Immune system & allergy, Infections clinical trials.
This trial studies ways to protect babies who were exposed to HIV before birth but are not infected themselves. It aims to find better interventions to prevent severe infections in these infants.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and have HIV.
- Your baby will be exposed to HIV but not infected.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an experimental HIV vaccine, given with an adjuvant to boost the immune response, is safe and produces an immune response in infants who were exposed to HIV in the womb but are not infected. The study aims to help protect these vulnerable infants.
This study gives a specific probiotic (from B. infantis) to babies born without HIV to see if it can improve the baby’s early immune health. It focuses on babies who are HIV-exposed because their mother has HIV and plans to exclusively breastfeed for the first 6 months.
This study gives very early, intensive HIV medicine to infants diagnosed with HIV and follows them closely to see if HIV can go into remission (stop being detectable without ongoing treatment). It may help families understand whether treating right after birth can change a child’s long-term HIV outlook.
This trial tests whether giving a special neutralizing antibody (bNAb) early to infants living with HIV can help their immune system fight the virus better. It's for babies under 1 year old who are starting HIV treatment for the first time.
This study tests whether giving a combination of two lab-made antibodies (PGT121.414.LS and VRC07-523LS) to newborns exposed to HIV during pregnancy is safe and how the body processes them. It may help protect infants from getting HIV after birth.
This trial tests whether giving early neutralizing antibodies can help infants living with HIV control the virus better. It aims to improve their long-term health.
Hear when a new Gut Microbiome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.